{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03861",
    "Peptide Name": "GLRC-3 (Synthetic AMPs, variant of GLR-19, Arg-rich; Leu-rich; 1S=S, UCSS1a)",
    "Source": "De novo designed, man-made sequences",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "GLRRLCGRLGRRLCRLLLR",
    "Sequence Length": 19,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Antiviral",
      "Anti-HIV"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 7,
    "Boman Index": 3.4,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "47%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is poorly similar (84.21%) toGLR-19. R: 37%; L: 37%.Chemical modification:  one disulfide bond C6-C14.Activity: inhibited HSV-2MS in Vero cells (EC50 6.37 ug/ml); HSV-2MS in Vero cells (EC50 15 ug/ml). E. coli (MIC 7.5 uM); B.subtilis (MIC >120 uM).Toxicity: TC50 18.5 ug/ml in CEM-SS cells.",
    "Author": "Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2011",
    "Reference": "J AIDS Clinic Res S2:003. doi:10.4172/2155-6113.S2-003.Wang HIV screen project",
    "Title": "De Novo Design of Antiviral and Antibacterial Peptides with \nVarying Loop Structures"
  },
  "3D Structure": []
}